Shree Ganesh Remedies Limited
BSE: SGRL.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Chandulal Manubhai Kothia
- Employees
- 139
- Headquarters
- Ankleshwar, India
- IPO year
- 2024
- Market cap
- ₹6.8B
- Website
- http://www.ganeshremedies.com
Loading SGRL…
Loading profile data…Frequently asked questions about SGRL
What does Shree Ganesh Remedies Limited (SGRL.BO) do?
Shree Ganesh Remedies Ltd. engages in the research, development, manufacture, and marketing of healthcare products. Its products include intermediate and pharmaceuticals, veterinary products, and bulk drugs. The company was founded on April 27, 1995 and is headquartered in Ankleshwar, India.
Where does SGRL.BO trade?
Shree Ganesh Remedies Limited (SGRL.BO) trades on the Bombay Stock Exchange.
What sector is SGRL.BO in?
Shree Ganesh Remedies Limited (SGRL.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Shree Ganesh Remedies Limited?
Chandulal Manubhai Kothia is the chief executive officer of Shree Ganesh Remedies Limited (SGRL.BO).
Where is Shree Ganesh Remedies Limited headquartered?
Shree Ganesh Remedies Limited is headquartered in India.
Does SGRL.BO pay a dividend?
Shree Ganesh Remedies Limited (SGRL.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SGRL.BO go public?
Shree Ganesh Remedies Limited (SGRL.BO) completed its initial public offering in 2024.